|
Allakos Inc (NASDAQ: ALLK) |
|
|
|
| |
Allakos Inc 's vs. its Competitors Results
(List of Competitors, Financial Results 12 Months from the last period ending MRQ, in Millions of $)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
REVENUE |
NET INCOME |
NET MARGIN |
CASH FLOW |
| Allakos Inc |
1 Q 2025 |
ALLK |
0.00 |
-70.85 |
- |
-20.31 |
| Sanofi |
4 Q 2024 |
SNY |
49,599.72 |
6,292.16 |
12.69 % |
11,309.76 |
| Novartis Ag |
4 Q 2023 |
NVS |
46,660.00 |
14,854.00 |
31.83 % |
12,407.00 |
| Astrazeneca Plc |
4 Q 2023 |
AZN |
45,811.00 |
5,961.00 |
13.01 % |
6,166.00 |
| Takeda Pharmaceutical Company Limited |
1 Q 2024 |
TAK |
29,166.69 |
986.39 |
3.38 % |
5,739.41 |
| Johnson and Johnson |
1 Q 2025 |
JNJ |
89,331.00 |
21,810.00 |
24.41 % |
13,001.00 |
| Merck and Co Inc |
1 Q 2025 |
MRK |
63,922.00 |
17,451.00 |
27.3 % |
3,061.00 |
| Pfizer Inc |
1 Q 2025 |
PFE |
62,463.00 |
7,912.00 |
12.67 % |
702.00 |
| Abbvie Inc |
1 Q 2025 |
ABBV |
57,367.00 |
4,203.00 |
7.33 % |
-12,892.00 |
| Eli Lilly And Company |
1 Q 2025 |
LLY |
49,003.20 |
11,106.40 |
22.66 % |
633.10 |
| Bristol myers Squibb Company |
1 Q 2025 |
BMY |
47,636.00 |
5,437.00 |
11.41 % |
1,541.00 |
| Amgen Inc |
4 Q 2024 |
AMGN |
33,424.00 |
4,090.00 |
12.24 % |
1,029.00 |
| Gilead Sciences Inc |
1 Q 2025 |
GILD |
28,735.00 |
5,965.00 |
20.76 % |
3,208.00 |
| Teva Pharmaceutical Industries Limited |
1 Q 2025 |
TEVA |
16,617.00 |
-1,320.00 |
-7.94 % |
-1,293.00 |
| Viatris Inc |
1 Q 2025 |
VTRS |
14,330.20 |
-3,790.10 |
-26.45 % |
-259.60 |
| Regeneron Pharmaceuticals Inc |
1 Q 2025 |
REGN |
14,085.70 |
4,499.30 |
31.94 % |
483.20 |
| Organon and Co |
1 Q 2025 |
OGN |
6,294.00 |
750.00 |
11.92 % |
-28.00 |
| Beigene Ltd |
1 Q 2025 |
ONC |
0.00 |
0.00 |
- |
-276.85 |
| Legend Biotech Corporation |
4 Q 2023 |
LEGN |
285.14 |
-518.25 |
-181.75 % |
455.69 |
| Morphosys Ag |
4 Q 2023 |
MOR |
266.87 |
-212.50 |
-79.63 % |
122.97 |
| Arvinas Inc |
1 Q 2025 |
ARVN |
426.90 |
-46.60 |
-10.92 % |
-12.50 |
| Blueprint Medicines Corporation |
1 Q 2025 |
BPMC |
562.12 |
-155.73 |
-27.7 % |
10.24 |
| Biocryst Pharmaceuticals Inc |
1 Q 2025 |
BCRX |
503.49 |
-53.47 |
-10.62 % |
20.75 |
| Tg Therapeutics Inc |
1 Q 2025 |
TGTX |
386.39 |
39.15 |
10.13 % |
56.68 |
| Immunogen inc |
3 Q 2023 |
IMGN |
287.61 |
-73.52 |
-25.56 % |
296.02 |
| Zai Lab Limited |
1 Q 2025 |
ZLAB |
418.33 |
-252.07 |
-60.26 % |
106.48 |
| Myovant Sciences Ltd |
4 Q 2023 |
MYOV |
379.11 |
-183.77 |
-48.47 % |
-211.08 |
| Travere Therapeutics Inc |
1 Q 2025 |
TVTX |
273.53 |
-226.71 |
-82.88 % |
18.65 |
| Mannkind Corporation |
1 Q 2025 |
MNKD |
297.60 |
30.12 |
10.12 % |
-145.22 |
| Evolus Inc |
1 Q 2025 |
EOLS |
380.30 |
-56.20 |
-14.78 % |
-29.06 |
| Esperion Therapeutics Inc |
1 Q 2025 |
ESPR |
259.57 |
-153.22 |
-59.03 % |
-111.98 |
| Revance Therapeutics Inc |
3 Q 2024 |
RVNC |
247.00 |
-1.63 |
-0.66 % |
-122.13 |
| Cytomx Therapeutics Inc |
1 Q 2025 |
CTMX |
147.56 |
41.60 |
28.19 % |
11.53 |
| Puma Biotechnology Inc |
1 Q 2025 |
PBYI |
232.71 |
38.07 |
16.36 % |
-13.72 |
| Deciphera Pharmaceuticals Inc |
1 Q 2024 |
DCPH |
174.91 |
-190.42 |
-108.87 % |
-23.39 |
| Xencor Inc |
1 Q 2025 |
XNCR |
127.23 |
-211.06 |
-165.89 % |
8.54 |
| Day One Biopharmaceuticals Inc |
1 Q 2025 |
DAWN |
161.92 |
-79.14 |
-48.87 % |
-237.03 |
| Casi Pharmaceuticals inc |
4 Q 2024 |
CASI |
28.54 |
-39.26 |
-137.57 % |
-18.36 |
| Protagonist Therapeutics inc |
1 Q 2025 |
PTGX |
207.80 |
56.19 |
27.04 % |
-32.92 |
| Merus N v |
1 Q 2025 |
MRUS |
54.73 |
-277.34 |
-506.73 % |
18.97 |
| Adc Therapeutics Sa |
1 Q 2025 |
ADCT |
75.82 |
-149.84 |
-197.64 % |
-39.71 |
| Syndax Pharmaceuticals Inc |
1 Q 2025 |
SNDX |
43.72 |
-331.20 |
-757.52 % |
39.38 |
| G1 Therapeutics Inc |
2 Q 2024 |
GTHX |
58.20 |
-44.77 |
-76.93 % |
-40.90 |
| Mirati Therapeutics Inc |
3 Q 2023 |
MRTX |
38.19 |
-725.88 |
-1900.65 % |
-40.13 |
| Kura Oncology Inc |
1 Q 2025 |
KURA |
0.00 |
-181.89 |
- |
9.76 |
| Macrogenics Inc |
1 Q 2025 |
MGNX |
154.05 |
-55.81 |
-36.23 % |
65.22 |
| Journey Medical Corp |
1 Q 2025 |
DERM |
56.24 |
-8.30 |
-14.76 % |
-2.99 |
| Nektar Therapeutics |
1 Q 2025 |
NKTR |
87.25 |
-133.04 |
-152.49 % |
-9.75 |
| Gossamer Bio Inc |
1 Q 2025 |
GOSS |
124.59 |
-51.24 |
-41.13 % |
-9.84 |
| Affimed N v |
4 Q 2023 |
AFMD |
9.27 |
-118.65 |
-1280.22 % |
164.48 |
| Whitehawk Therapeutics Inc |
1 Q 2025 |
WHWK |
0.00 |
0.00 |
- |
173.73 |
| Adlai Nortye Ltd |
4 Q 2023 |
ANL |
5.00 |
-104.87 |
-2097.42 % |
0.00 |
| Xilio Therapeutics inc |
1 Q 2025 |
XLO |
9.27 |
-54.30 |
-585.54 % |
54.12 |
| Aravive Inc |
3 Q 2023 |
ARAV |
7.00 |
-39.85 |
-569.65 % |
13.54 |
| Tonix Pharmaceuticals Holding Corp |
1 Q 2025 |
TNXP |
10.04 |
-131.93 |
-1313.87 % |
124.67 |
| Immuron Limited |
2 Q 2023 |
IMRN |
1.48 |
-3.79 |
-255.78 % |
3.25 |
| Abeona Therapeutics Inc |
1 Q 2025 |
ABEO |
4.71 |
-44.19 |
-937.51 % |
-1.62 |
| Bolt Biotherapeutics Inc |
1 Q 2025 |
BOLT |
3.64 |
-63.35 |
-1741.26 % |
4.13 |
| Oncternal Therapeutics Inc |
3 Q 2024 |
ONCT |
2.16 |
-34.58 |
-1599.95 % |
-1.85 |
| Therapeuticsmd Inc |
1 Q 2025 |
TXMD |
1.41 |
-3.44 |
-244.46 % |
-66.51 |
| Northwest Biotherapeutics Inc |
1 Q 2025 |
NWBO |
1.47 |
-85.92 |
-5832.99 % |
0.30 |
| Vaccinex Inc |
4 Q 2024 |
VCNX |
-0.60 |
-18.63 |
- |
-0.43 |
| Lyra Therapeutics Inc |
1 Q 2025 |
LYRA |
1.19 |
-79.53 |
-6711.39 % |
15.94 |
| Adagene Inc |
4 Q 2024 |
ADAG |
0.10 |
-33.42 |
-32386.45 % |
0.00 |
| Chimerix Inc |
4 Q 2024 |
CMRX |
33.06 |
-88.39 |
-267.39 % |
3.39 |
| Zentalis Pharmaceuticals Inc |
1 Q 2025 |
ZNTL |
0.00 |
-224.19 |
- |
4.26 |
| Allarity Therapeutics Inc |
1 Q 2025 |
ALLR |
23.79 |
-23.94 |
-100.6 % |
27.71 |
| Nucana Plc |
4 Q 2023 |
NCNA |
0.00 |
-27.63 |
- |
87.36 |
| Nanoviricides inc |
1 Q 2025 |
NNVC |
0.00 |
-9.73 |
- |
-0.71 |
| Olema Pharmaceuticals Inc |
1 Q 2025 |
OLMA |
0.00 |
-128.89 |
- |
16.92 |
| Medicinova Inc |
1 Q 2025 |
MNOV |
0.00 |
-11.16 |
- |
-10.57 |
| Essa Pharma inc |
1 Q 2025 |
EPIX |
0.60 |
-28.50 |
-4743.37 % |
-5.37 |
| Repare Therapeutics Inc |
1 Q 2025 |
RPTX |
68.68 |
-127.89 |
-186.21 % |
-18.76 |
| Janux Therapeutics Inc |
1 Q 2025 |
JANX |
13.05 |
-77.74 |
-595.77 % |
-139.06 |
| Werewolf Therapeutics Inc |
1 Q 2025 |
HOWL |
16.22 |
-72.41 |
-446.4 % |
-67.16 |
| Syros Pharmaceuticals Inc |
3 Q 2024 |
SYRS |
23.44 |
-97.82 |
-417.37 % |
-54.91 |
| Innovation Pharmaceuticals Inc |
3 Q 2024 |
CTIX |
0.00 |
-2.62 |
- |
-2.10 |
| Cadrenal Therapeutics Inc |
1 Q 2025 |
CVKD |
0.00 |
-10.65 |
- |
1.56 |
| Oric Pharmaceuticals Inc |
1 Q 2025 |
ORIC |
0.00 |
-132.86 |
- |
-7.03 |
| Checkpoint Therapeutics inc |
1 Q 2025 |
CKPT |
0.36 |
-56.51 |
-15828.29 % |
21.80 |
| Rapt Therapeutics Inc |
1 Q 2025 |
RAPT |
3.25 |
-116.51 |
-3586 % |
14.94 |
| Eqrx Inc |
3 Q 2023 |
EQRX |
0.00 |
-259.62 |
- |
-682.35 |
| Shattuck Labs Inc |
1 Q 2025 |
STTK |
6.41 |
-70.61 |
-1102.04 % |
-15.11 |
| Tyme Technologies Inc. |
2 Q 2023 |
TYME |
0.00 |
-24.19 |
- |
-30.04 |
| Viracta Therapeutics Inc |
3 Q 2024 |
VIRX |
0.00 |
-43.29 |
- |
0.27 |
| Nuvalent Inc |
1 Q 2025 |
NUVL |
4.23 |
-300.86 |
-7107.39 % |
22.32 |
| Cns Pharmaceuticals Inc |
1 Q 2025 |
CNSP |
0.03 |
-15.61 |
-45366.88 % |
12.23 |
| Oncosec Medical Incorporated |
4 Q 2023 |
ONCS |
0.00 |
-29.39 |
- |
-21.55 |
| Atea Pharmaceuticals Inc |
1 Q 2025 |
AVIR |
0.00 |
-169.52 |
- |
-24.43 |
| Cellectar Biosciences Inc |
1 Q 2025 |
CLRB |
0.00 |
-24.54 |
- |
-26.13 |
| Mineralys Therapeutics Inc |
1 Q 2025 |
MLYS |
0.00 |
-188.51 |
- |
74.59 |
| Cytodyn inc |
1 Q 2025 |
CYDY |
0.00 |
-7.09 |
- |
8.38 |
| Erasca Inc |
1 Q 2025 |
ERAS |
0.00 |
-157.60 |
- |
-6.24 |
| Sagimet Biosciences inc |
1 Q 2025 |
SGMT |
0.00 |
-57.11 |
- |
0.70 |
| Ideaya Biosciences Inc |
1 Q 2025 |
IDYA |
49.87 |
-307.08 |
-615.75 % |
21.70 |
| Kinnate Biopharma Inc |
3 Q 2023 |
KNTE |
0.00 |
-127.15 |
- |
-9.31 |
| Spyre Therapeutics Inc |
1 Q 2025 |
SYRE |
5.81 |
-208.93 |
-3599.21 % |
-179.38 |
| Mural Oncology Plc |
1 Q 2025 |
MURA |
0.00 |
-130.73 |
- |
-0.58 |
| Panbela Therapeutics Inc |
3 Q 2024 |
PBLA |
0.00 |
-27.92 |
- |
-0.77 |
| Alx Oncology Holdings Inc |
1 Q 2025 |
ALXO |
0.00 |
-130.02 |
- |
6.57 |
| Nextcure Inc |
1 Q 2025 |
NXTC |
0.00 |
-49.52 |
- |
3.47 |
| Biomea Fusion Inc |
1 Q 2025 |
BMEA |
0.00 |
-138.43 |
- |
-109.05 |
| Cogent Biosciences Inc |
1 Q 2025 |
COGT |
7.87 |
-269.50 |
-3423.92 % |
-89.80 |
| Effector Therapeutics Inc |
1 Q 2024 |
EFTR |
0.00 |
-34.63 |
- |
5.20 |
| Immuneering Corporation |
1 Q 2025 |
IMRX |
0.32 |
-61.77 |
-19490.3 % |
-30.42 |
| Verastem Inc |
1 Q 2025 |
VSTM |
3.64 |
-148.88 |
-4086.66 % |
35.22 |
| Lantern Pharma Inc |
1 Q 2025 |
LTRN |
0.00 |
-19.88 |
- |
-11.98 |
| Biophytis Sa |
4 Q 2023 |
BPTS |
0.00 |
-19.07 |
- |
6.55 |
| Abvc Biopharma Inc |
1 Q 2025 |
ABVC |
0.52 |
-6.33 |
-1209.57 % |
-0.05 |
| Atossa Therapeutics Inc |
1 Q 2025 |
ATOS |
0.00 |
-26.34 |
- |
-18.84 |
| Rain Oncology Inc |
3 Q 2023 |
RAIN |
0.00 |
-72.26 |
- |
-39.70 |
| Prelude Therapeutics Inc |
1 Q 2025 |
PRLD |
0.00 |
-127.83 |
- |
15.56 |
| Genprex Inc |
1 Q 2025 |
GNPX |
0.00 |
-19.38 |
- |
-4.75 |
| I mab |
4 Q 2024 |
IMAB |
3.89 |
-22.23 |
-571.02 % |
-193.82 |
| Theseus Pharmaceuticals Inc |
3 Q 2023 |
THRX |
0.00 |
-56.61 |
- |
-197.75 |
| Iterum Therapeutics Plc |
1 Q 2025 |
ITRM |
14.32 |
-22.56 |
-157.56 % |
5.26 |
| APROX. MARKET |
1 Q |
SUBTOTAL |
661,528.42 |
96,499.69 |
14.59 % |
43,553.16 |
|
